Marko Jovanovic
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (16)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
A protein’s molecular interactions and post-translational modifications (PTMs), such as phosphorylation, can be co-dependent and reciprocally co-regulate each other. Although this interplay is central for many biological processes, a systematic method to simultaneously study assembly states and PTMs from the same sample is critically missing. Here, we introduce SEC-MX (Size Exclusion Chromatography fractions MultipleXed), a global quantitative method combining Size Exclusion Chromatography and PTM-enrichment for simultaneous characterization of PTMs and assembly states. SEC-MX enhances throughput, allows phosphopeptide enrichment, and facilitates quantitative differential comparisons between biological conditions. Conducting SEC-MX on HEK293 and HCT116 cells, we generate a proof-of-concept dataset, mapping thousands of phosphopeptides and their assembly states. Our analysis reveals intricate relationships between phosphorylation events and assembly states and generates testable hypotheses for follow-up studies. Overall, we establish SEC-MX as a valuable tool for exploring protein functions and regulation beyond abundance changes.
Year:
2025
The rapid identification of protein–protein interactions has been significantly enabled by mass spectrometry (MS) proteomics‐based methods, including affinity purification‐MS, crosslinking‐MS, and proximity‐labeling proteomics. While these methods can reveal networks of interacting proteins, they cannot reveal how specific protein–protein interactions alter protein function or cell signaling. For instance, when two proteins interact, there can be emergent signaling processes driven purely by the individual activities of those proteins being co‐localized. Alternatively, protein–protein interactions can allosterically regulate function, enhancing or suppressing activity in response to binding. In this work, we investigate the interaction between the tyrosine phosphatase PTP1B and the adaptor protein Grb2, which have been annotated as binding partners in a number of proteomics studies. This interaction has been postulated to co‐localize PTP1B with its substrate IRS‐1 by forming a ternary complex, thereby enhancing the dephosphorylation of IRS‐1 to suppress insulin signaling. Here, we report that Grb2 binding to PTP1B also allosterically enhances PTP1B catalytic activity. We show that this interaction is dependent on the proline‐rich region of PTP1B, which interacts with the C‐terminal SH3 domain of Grb2. Using NMR spectroscopy and hydrogen‐deuterium exchange mass spectrometry (HDX‐MS) we show that Grb2 binding alters PTP1B structure and/or dynamics. Finally, we use MS proteomics to identify other interactors of the PTP1B proline‐rich region that may also regulate PTP1B function similarly to Grb2. This work presents one of the first examples of a protein allosterically regulating the enzymatic activity of PTP1B and lays the foundation for discovering new mechanisms of PTP1B regulation in cell signaling.
Year:
2025
Missense mutations in PTPN11 , which encodes the protein tyrosine phosphatase SHP2, are common in several developmental disorders and cancers. While many mutations disrupt auto-inhibition and hyperactivate SHP2, several do not enhance catalytic activity. Both activating and non-activating mutations could potentially drive pathogenic signaling by altering SHP2 interactions or localization. We employed proximity-labeling proteomics to map the interaction networks of wild-type SHP2, ten clinically relevant mutants, and SHP2 bound to an inhibitor that stabilizes its auto-inhibited state. Our analyses reveal mutation- and inhibitor-dependent alterations in the SHP2 interactome, with several mutations also changing localization. Some mutants show increased mitochondrial localization and impact mitochondrial function. This study provides a resource for exploring SHP2 signaling and offers new insights into the molecular basis of SHP2-driven diseases. Furthermore, this work highlights the capacity for proximity-labeling proteomics to detect missense-mutation-dependent changes in protein interactions and localization.
Year:
2025
During the switch from progenitor to differentiated cell, cellular physiology must change to accommodate increased translation and trafficking of membrane-bound proteins. We identify RNA-binding and E3 ubiquitin ligase Mex3a as a key driver of proper neuronal differentiation by regulating mRNA translation and trafficking of cell surface proteins in the context of Unfolded Protein Response (UPR) signaling. Loss of Mex3a in immature olfactory sensory neurons (OSNs) leads to defects in cilia structure, cell surface protein expression, and planar cell polarity in mature OSNs. Proteomics reveal a Mex3a-dependent decrease in proteins related to vesicle transport, lipid metabolism, and ribosome biogenesis. We identify RNA and ubiquitin targets of Mex3a and provide evidence that Mex3a may confer K27 ubiquitin linkage on substrates. Finally, modulating cellular levels of Mex3a changes the recruitment of translation factors Serbp1 and p-eEF2 to ribosomes with possible effects on translation. Our data reveal how a stemness factor regulates development post-transcriptionally and post-translationally to ensure robust differentiation. Highlights Loss of stemness factor Mex3a in immature olfactory neurons leads to defects in mature olfactory neurons. Translation/Trafficking of cell surface proteins, cilia structure, and planar cell polarity are compromised in the absence of Mex3a. Mex3a may confer K27 ubiquitination on stress granule protein Serbp1 and ribosome protein Rps7. Mex3a levels are associated with Serbp1 and p-eEF2 recruitment to ribosomes.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2023
Collaborators (21)
Gloria Ann Brar
Professor
University of California, Berkeley
Stella Kang
Professor and Vice Chair
Columbia University Irving Medical Center
Rashmi Voleti
Columbia University
Andreas Martin
Professor
University of California, Berkeley
Valentina Loconte
Diamond Light Source
Jellert Gaublomme
Assistant Professor
Columbia University
Silvan Spiri
University of Zurich
Ziyuan Jiang
Weill Cornell Medicine
Kevin Monahan
Assistant Professor
Rutgers University - Busch Campus
Stavros Lomvardas
Professor
Columbia University
Jessey Erath
Brown University
Sergej Djuranovic
Professor
Brown University
Ann McDermott
Esther Breslow Professor of Biological Chemistry
Columbia University
Neel H Shah
Associate Professor
Columbia University
Daniel Keedy
Associate Professor
CUNY Advanced Science Research Center
Ataman Sendoel
Assistant Professor
University of Zurich
H. Tomas Rube
Assistant Professor
University of California Merced
Elçin Ünal
Professor
University of California
Liana Lareau
Assistant Professor
University of California, Berkeley
Gene W Yeo
University of California, San Diego
Eugenio F Fornasiero
Independent Group Leader
University Medical Center Göttingen
Make your next move.
Prepare your application
Review drafts before you send them.